BlueRock Therapeutics, a clinical stage cell therapy company and wholly owned, independently operated subsidiary of Bayer, has announced the clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA)...

Johnson & Johnson (J&J) has submitted its nipocalimab drug for approval from the US Food and Drug Administration (FDA). While the initial submission relates to use with patients with generalised myasthenia gravis, the company believes...